Symbol:
TTC9
Name:
tetratricopeptide repeat domain 9
RGD ID:
1318967
HGNC Page
HGNC:20267
Description:
Predicted to act upstream of or within bone development. Implicated in opiate dependence.
Type:
protein-coding
RefSeq Status:
REVIEWED
Previously known as:
KIAA0227; tetratricopeptide repeat protein 9A; TPR repeat protein 9A; TTC9A
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Mus musculus (house mouse):
Ttc9 (tetratricopeptide repeat domain 9)
HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Ttc9 (tetratricopeptide repeat domain 9)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther
Chinchilla lanigera (long-tailed chinchilla):
Ttc9 (tetratricopeptide repeat domain 9)
NCBI
Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):
TTC9 (tetratricopeptide repeat domain 9)
NCBI
Ortholog
Canis lupus familiaris (dog):
TTC9 (tetratricopeptide repeat domain 9)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Ttc9 (tetratricopeptide repeat domain 9)
NCBI
Ortholog
Sus scrofa (pig):
TTC9 (tetratricopeptide repeat domain 9)
HGNC
EggNOG, Ensembl, NCBI, OMA, OrthoDB, Panther, Treefam
Chlorocebus sabaeus (green monkey):
TTC9 (tetratricopeptide repeat domain 9)
NCBI
Ortholog
Heterocephalus glaber (naked mole-rat):
Ttc9 (tetratricopeptide repeat domain 9)
NCBI
Ortholog
Alliance orthologs 3
Mus musculus (house mouse):
Ttc9 (tetratricopeptide repeat domain 9)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Rattus norvegicus (Norway rat):
Ttc9 (tetratricopeptide repeat domain 9)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus laevis (African clawed frog):
ttc9.L
Alliance
DIOPT (Xenbase)
Xenopus tropicalis (tropical clawed frog):
ttc9
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus laevis (African clawed frog):
ttc9.S
Alliance
DIOPT (Xenbase)
Allele / Splice:
See ClinVar data
Latest Assembly:
GRCh38 - Human Genome Assembly GRCh38
Position:
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 14 70,641,916 - 70,675,366 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 14 70,641,916 - 70,675,366 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 14 71,108,633 - 71,142,083 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 14 70,178,257 - 70,211,830 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 14 51,172,455 - 51,206,028 (+) NCBI Celera Cytogenetic Map 14 q24.2 NCBI HuRef 14 51,277,148 - 51,310,717 (+) NCBI HuRef CHM1_1 14 71,046,680 - 71,080,246 (+) NCBI CHM1_1 T2T-CHM13v2.0 14 64,847,902 - 64,881,350 (+) NCBI T2T-CHM13v2.0
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
TTC9 Human (+)-schisandrin B multiple interactions ISO RGD:1565985 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TTC9 mRNA] CTD PMID:31150632 TTC9 Human 1,2-dichloroethane decreases expression ISO RGD:1551119 6480464 ethylene dichloride results in decreased expression of TTC9 mRNA CTD PMID:28960355 TTC9 Human 17alpha-ethynylestradiol increases expression ISO RGD:1565985 6480464 Ethinyl Estradiol results in increased expression of TTC9 mRNA CTD PMID:29097150 TTC9 Human 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of TTC9 mRNA CTD PMID:30165855 TTC9 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of TTC9 mRNA CTD PMID:22298810 TTC9 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1565985 6480464 Tetrachlorodibenzodioxin results in decreased expression of TTC9 mRNA CTD PMID:32109520 TTC9 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1565985 6480464 Tetrachlorodibenzodioxin affects the expression of TTC9 mRNA CTD PMID:22298810 TTC9 Human 4,4'-sulfonyldiphenol affects methylation ISO RGD:1551119 6480464 bisphenol S affects the methylation of TTC9 gene CTD PMID:31683443 TTC9 Human 4-hydroxyphenyl retinamide increases expression ISO RGD:1551119 6480464 Fenretinide results in increased expression of TTC9 mRNA CTD PMID:28973697 TTC9 Human 6-propyl-2-thiouracil increases expression ISO RGD:1565985 6480464 Propylthiouracil results in increased expression of TTC9 mRNA CTD PMID:30047161 TTC9 Human 8-Br-cAMP increases expression EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TTC9 mRNA CTD PMID:22079614 TTC9 Human aflatoxin B1 increases expression ISO RGD:1565985 6480464 Aflatoxin B1 results in increased expression of TTC9 mRNA CTD PMID:23630614 TTC9 Human aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of TTC9 intron CTD PMID:30157460 TTC9 Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of TTC9 mRNA CTD PMID:23724009 TTC9 Human amitrole increases expression ISO RGD:1565985 6480464 Amitrole results in increased expression of TTC9 mRNA CTD PMID:30047161 TTC9 Human atrazine affects methylation ISO RGD:1565985 6480464 Atrazine affects the methylation of TTC9 gene CTD PMID:35440735 TTC9 Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of TTC9 promoter CTD PMID:27901495 TTC9 Human bisphenol A affects expression ISO RGD:1565985 6480464 bisphenol A affects the expression of TTC9 mRNA CTD PMID:25181051 TTC9 Human bisphenol A increases expression ISO RGD:1551119 6480464 bisphenol A results in increased expression of TTC9 mRNA CTD PMID:32156529 TTC9 Human bisphenol A decreases expression EXP 6480464 bisphenol A analog results in decreased expression of TTC9 mRNA CTD PMID:32387340 TTC9 Human bisphenol A increases methylation ISO RGD:1565985 6480464 bisphenol A results in increased methylation of TTC9 gene CTD PMID:28505145 TTC9 Human cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of TTC9 mRNA CTD PMID:21120746 TTC9 Human cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of TTC9 mRNA CTD PMID:38568856 TTC9 Human calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of TTC9 mRNA CTD PMID:26485663 TTC9 Human carbon nanotube increases expression ISO RGD:1551119 6480464 Nanotubes, Carbon analog results in increased expression of TTC9 mRNA; Nanotubes, Carbon results in increased more ... CTD PMID:25554681 TTC9 Human chloroprene increases expression ISO RGD:1551119 6480464 Chloroprene results in increased expression of TTC9 mRNA CTD PMID:23125180 TTC9 Human cisplatin multiple interactions ISO RGD:1551119 6480464 [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of more ... CTD PMID:23625948 TTC9 Human cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of TTC9 mRNA CTD PMID:27392435 TTC9 Human copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of TTC9 mRNA CTD PMID:19549813 TTC9 Human corosolic acid increases expression EXP 6480464 corosolic acid results in increased expression of TTC9 mRNA CTD PMID:37939859 TTC9 Human coumestrol multiple interactions EXP 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of TTC9 mRNA CTD PMID:19167446 TTC9 Human coumestrol decreases expression EXP 6480464 Coumestrol results in decreased expression of TTC9 mRNA CTD PMID:19167446 TTC9 Human Cuprizon decreases expression ISO RGD:1565985 6480464 Cuprizone results in decreased expression of TTC9 mRNA CTD PMID:26577399 TTC9 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of TTC9 mRNA CTD PMID:25562108 TTC9 Human dibutyl phthalate decreases expression ISO RGD:1565985 6480464 Dibutyl Phthalate results in decreased expression of TTC9 mRNA CTD PMID:21266533 TTC9 Human dioxygen multiple interactions ISO RGD:1565985 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression more ... CTD PMID:33729688 TTC9 Human diuron decreases expression ISO RGD:1565985 6480464 Diuron results in decreased expression of TTC9 mRNA CTD PMID:21551480 TTC9 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 TTC9 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of TTC9 mRNA CTD PMID:29803840 TTC9 Human endosulfan increases expression ISO RGD:1565985 6480464 Endosulfan results in increased expression of TTC9 mRNA CTD PMID:29391264 TTC9 Human fenvalerate increases expression ISO RGD:1565985 6480464 fenvalerate results in increased expression of TTC9 mRNA CTD PMID:30307764 TTC9 Human furan increases expression ISO RGD:1565985 6480464 furan results in increased expression of TTC9 mRNA CTD PMID:27387713 TTC9 Human kojic acid increases expression EXP 6480464 kojic acid results in increased expression of TTC9 mRNA CTD PMID:16595896 TTC9 Human lead(0) affects expression EXP 6480464 Lead affects the expression of TTC9 mRNA CTD PMID:28903495 TTC9 Human malathion decreases expression EXP 6480464 Malathion results in decreased expression of TTC9 mRNA CTD PMID:37047231 TTC9 Human methimazole increases expression ISO RGD:1565985 6480464 Methimazole results in increased expression of TTC9 mRNA CTD PMID:30047161 TTC9 Human N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of TTC9 mRNA CTD PMID:24810058 TTC9 Human nickel atom increases expression EXP 6480464 Nickel results in increased expression of TTC9 mRNA CTD PMID:25583101 TTC9 Human okadaic acid increases expression EXP 6480464 Okadaic Acid results in increased expression of TTC9 mRNA CTD PMID:38832940 TTC9 Human ozone multiple interactions ISO RGD:1551119 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased more ... CTD PMID:34911549 TTC9 Human paracetamol affects expression ISO RGD:1551119 6480464 Acetaminophen affects the expression of TTC9 mRNA CTD PMID:17562736 TTC9 Human paracetamol increases expression ISO RGD:1565985 6480464 Acetaminophen results in increased expression of TTC9 mRNA CTD PMID:33387578 TTC9 Human paraquat increases expression ISO RGD:1565985 6480464 Paraquat results in increased expression of TTC9 mRNA CTD PMID:32680482 TTC9 Human perfluorohexanesulfonic acid increases expression ISO RGD:1551119 6480464 perfluorohexanesulfonic acid results in increased expression of TTC9 mRNA CTD PMID:37995155 TTC9 Human phenylmercury acetate increases expression EXP 6480464 Phenylmercuric Acetate results in increased expression of TTC9 mRNA CTD PMID:26272509 TTC9 Human phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 TTC9 Human pirinixic acid increases expression ISO RGD:1551119 6480464 pirinixic acid results in increased expression of TTC9 mRNA CTD PMID:21318169 TTC9 Human pirinixic acid multiple interactions ISO RGD:1551119 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of TTC9 mRNA] CTD PMID:21318169 TTC9 Human pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1565985 6480464 Pregnenolone Carbonitrile results in increased expression of TTC9 mRNA CTD PMID:30047161 TTC9 Human resveratrol multiple interactions EXP 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of TTC9 mRNA CTD PMID:19167446 TTC9 Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 TTC9 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of TTC9 mRNA CTD PMID:38568856 TTC9 Human Soman increases expression ISO RGD:1565985 6480464 Soman results in increased expression of TTC9 mRNA CTD PMID:19281266 TTC9 Human sulfadimethoxine increases expression ISO RGD:1565985 6480464 Sulfadimethoxine results in increased expression of TTC9 mRNA CTD PMID:30047161 TTC9 Human testosterone enanthate affects expression EXP 6480464 testosterone enanthate affects the expression of TTC9 mRNA CTD PMID:17440010 TTC9 Human tetrachloromethane increases expression ISO RGD:1565985 6480464 Carbon Tetrachloride results in increased expression of TTC9 mRNA CTD PMID:31150632 TTC9 Human tetrachloromethane multiple interactions ISO RGD:1565985 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TTC9 mRNA] CTD PMID:31150632 TTC9 Human thioacetamide increases expression ISO RGD:1565985 6480464 Thioacetamide results in increased expression of TTC9 mRNA CTD PMID:23411599|PMID:34492290 TTC9 Human titanium dioxide decreases expression ISO RGD:1551119 6480464 titanium dioxide results in decreased expression of TTC9 mRNA CTD PMID:23557971 TTC9 Human titanium dioxide decreases methylation ISO RGD:1551119 6480464 titanium dioxide results in decreased methylation of TTC9 gene CTD PMID:35295148 TTC9 Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of TTC9 mRNA CTD PMID:37042841 TTC9 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of TTC9 mRNA CTD PMID:19101580|PMID:27188386 TTC9 Human zoledronic acid increases expression EXP 6480464 zoledronic acid results in increased expression of TTC9 mRNA CTD PMID:24714768
TTC9 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 14 70,641,916 - 70,675,366 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 14 70,641,916 - 70,675,366 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 14 71,108,633 - 71,142,083 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 14 70,178,257 - 70,211,830 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 14 51,172,455 - 51,206,028 (+) NCBI Celera Cytogenetic Map 14 q24.2 NCBI HuRef 14 51,277,148 - 51,310,717 (+) NCBI HuRef CHM1_1 14 71,046,680 - 71,080,246 (+) NCBI CHM1_1 T2T-CHM13v2.0 14 64,847,902 - 64,881,350 (+) NCBI T2T-CHM13v2.0
Ttc9 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 12 81,678,023 - 81,714,331 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 12 81,678,023 - 81,714,331 (+) Ensembl GRCm39 Ensembl GRCm38 12 81,631,249 - 81,667,557 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 12 81,631,249 - 81,667,557 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 12 82,732,356 - 82,765,928 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 12 82,550,217 - 82,583,789 (+) NCBI MGSCv36 mm8 Celera 12 83,098,495 - 83,131,977 (+) NCBI Celera Cytogenetic Map 12 D1 NCBI cM Map 12 37.85 NCBI
Ttc9 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 6 107,064,527 - 107,099,361 (+) NCBI GRCr8 mRatBN7.2 6 101,333,274 - 101,368,110 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 6 101,333,141 - 101,368,110 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 6 101,484,199 - 101,519,018 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 6 101,783,388 - 101,818,207 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 6 101,154,399 - 101,189,235 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 6 105,364,668 - 105,399,500 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 6 105,364,668 - 105,399,500 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 6 113,510,835 - 113,545,667 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 6 105,495,936 - 105,530,999 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 6 99,168,031 - 99,202,888 (+) NCBI Celera Cytogenetic Map 6 q24 NCBI
Ttc9 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 NW_004955523 4,438,674 - 4,471,049 (-) NCBI ChiLan1.0 ChiLan1.0
TTC9 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 15 71,760,138 - 71,793,953 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 14 70,976,652 - 71,010,466 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 14 51,229,734 - 51,262,455 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 14 70,100,391 - 70,132,551 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 14 70,100,391 - 70,130,915 (+) Ensembl panpan1.1 panPan2
TTC9 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 8 44,358,130 - 44,392,062 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 8 44,357,641 - 44,387,737 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 8 44,021,651 - 44,055,504 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 8 44,580,694 - 44,614,521 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 8 44,580,694 - 44,613,616 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 8 44,234,500 - 44,274,511 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 8 44,279,640 - 44,313,502 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 8 44,640,561 - 44,674,646 (+) NCBI UU_Cfam_GSD_1.0
Ttc9 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
TTC9 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 7 94,218,649 - 94,254,730 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 7 94,218,436 - 94,254,472 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 7 100,537,831 - 100,574,711 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
TTC9 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 24 47,845,463 - 47,878,891 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 24 47,846,449 - 47,877,325 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666053 36,067,908 - 36,102,438 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Ttc9 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 1716 Count of miRNA genes: 922 Interacting mature miRNAs: 1083 Transcripts: ENST00000256367 Prediction methods: Miranda Result types: miRGate_prediction
597244168 GWAS1340242_H sarcopenia QTL GWAS1340242 (human) 0.000006 sarcopenia 14 70668226 70668227 Human 597223215 GWAS1319289_H heel bone mineral density, urate measurement QTL GWAS1319289 (human) 8e-11 heel bone mineral density, urate measurement blood uric acid level (CMO:0000501) 14 70653617 70653618 Human 597160092 GWAS1256166_H 3-carboxy-4-methyl-5-propyl-2-furanpropanoate CMPF measurement QTL GWAS1256166 (human) 0.000004 3-carboxy-4-methyl-5-propyl-2-furanpropanoate CMPF measurement 14 70644644 70644645 Human 597429280 GWAS1525354_H protein measurement QTL GWAS1525354 (human) 7e-09 protein measurement 14 70671127 70671128 Human 597177975 GWAS1274049_H tetratricopeptide repeat protein 9B measurement QTL GWAS1274049 (human) 5e-39 tetratricopeptide repeat protein 9B measurement 14 70652446 70652447 Human
G38116
Human Assembly Chr Position (strand) Source JBrowse GRCh37 14 71,140,433 - 71,140,589 UniSTS GRCh37 Build 36 14 70,210,186 - 70,210,342 RGD NCBI36 Celera 14 51,204,384 - 51,204,540 RGD Cytogenetic Map 14 q24.2 UniSTS HuRef 14 51,309,073 - 51,309,229 UniSTS
A005T47
Human Assembly Chr Position (strand) Source JBrowse GRCh37 14 71,141,823 - 71,142,063 UniSTS GRCh37 Build 36 14 70,211,576 - 70,211,816 RGD NCBI36 Celera 14 51,205,774 - 51,206,014 RGD Cytogenetic Map 14 q24.2 UniSTS HuRef 14 51,310,463 - 51,310,703 UniSTS GeneMap99-GB4 RH Map 14 174.53 UniSTS
G20494
Human Assembly Chr Position (strand) Source JBrowse GRCh37 14 71,141,823 - 71,142,063 UniSTS GRCh37 Build 36 14 70,211,576 - 70,211,816 RGD NCBI36 Celera 14 51,205,774 - 51,206,014 RGD Cytogenetic Map 14 q24.2 UniSTS HuRef 14 51,310,463 - 51,310,703 UniSTS
G38256
Human Assembly Chr Position (strand) Source JBrowse GRCh37 14 71,112,906 - 71,113,142 UniSTS GRCh37 Build 36 14 70,182,659 - 70,182,895 RGD NCBI36 Celera 14 51,176,857 - 51,177,093 RGD Cytogenetic Map 14 q24.2 UniSTS HuRef 14 51,281,550 - 51,281,786 UniSTS
SHGC-3622
Human Assembly Chr Position (strand) Source JBrowse GRCh37 14 71,125,785 - 71,125,899 UniSTS GRCh37 Build 36 14 70,195,538 - 70,195,652 RGD NCBI36 Celera 14 51,189,737 - 51,189,851 RGD Cytogenetic Map 14 q24.2 UniSTS HuRef 14 51,294,416 - 51,294,540 UniSTS TNG Radiation Hybrid Map 14 24972.0 UniSTS
D14S906
Human Assembly Chr Position (strand) Source JBrowse GRCh37 14 71,141,858 - 71,142,027 UniSTS GRCh37 Build 36 14 70,211,611 - 70,211,780 RGD NCBI36 Celera 14 51,205,809 - 51,205,978 RGD Cytogenetic Map 14 q24.2 UniSTS HuRef 14 51,310,498 - 51,310,667 UniSTS
RH25433
Human Assembly Chr Position (strand) Source JBrowse GRCh37 14 71,141,619 - 71,141,772 UniSTS GRCh37 Build 36 14 70,211,372 - 70,211,525 RGD NCBI36 Celera 14 51,205,570 - 51,205,723 RGD Cytogenetic Map 14 q24.2 UniSTS HuRef 14 51,310,259 - 51,310,412 UniSTS GeneMap99-GB4 RH Map 14 174.43 UniSTS
G38244
Human Assembly Chr Position (strand) Source JBrowse GRCh37 14 71,138,536 - 71,138,857 UniSTS GRCh37 Build 36 14 70,208,289 - 70,208,610 RGD NCBI36 Celera 14 51,202,487 - 51,202,808 RGD Cytogenetic Map 14 q24.2 UniSTS HuRef 14 51,307,176 - 51,307,497 UniSTS
G20823
Human Assembly Chr Position (strand) Source JBrowse GRCh37 14 71,139,255 - 71,139,359 UniSTS GRCh37 Build 36 14 70,209,008 - 70,209,112 RGD NCBI36 Celera 14 51,203,206 - 51,203,310 RGD Cytogenetic Map 14 q24.2 UniSTS HuRef 14 51,307,895 - 51,307,999 UniSTS
A006H41
Human Assembly Chr Position (strand) Source JBrowse GRCh37 14 71,139,255 - 71,139,359 UniSTS GRCh37 Build 36 14 70,209,008 - 70,209,112 RGD NCBI36 Celera 14 51,203,206 - 51,203,310 RGD Cytogenetic Map 14 q24.2 UniSTS HuRef 14 51,307,895 - 51,307,999 UniSTS GeneMap99-GB4 RH Map 14 174.43 UniSTS
STS-Z40406
Human Assembly Chr Position (strand) Source JBrowse GRCh37 14 71,139,151 - 71,139,245 UniSTS GRCh37 Build 36 14 70,208,904 - 70,208,998 RGD NCBI36 Celera 14 51,203,102 - 51,203,196 RGD Cytogenetic Map 14 q24.2 UniSTS HuRef 14 51,307,791 - 51,307,885 UniSTS GeneMap99-GB4 RH Map 14 177.79 UniSTS NCBI RH Map 14 666.1 UniSTS
WI-20573
Human Assembly Chr Position (strand) Source JBrowse GRCh37 14 71,139,110 - 71,139,259 UniSTS GRCh37 Build 36 14 70,208,863 - 70,209,012 RGD NCBI36 Celera 14 51,203,061 - 51,203,210 RGD Cytogenetic Map 14 q24.2 UniSTS HuRef 14 51,307,750 - 51,307,899 UniSTS GeneMap99-GB4 RH Map 14 174.43 UniSTS Whitehead-RH Map 14 251.9 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
entire extraembryonic component
1204
2432
2788
2246
4941
1722
2344
5
621
1923
463
2246
7261
6434
51
3725
848
1734
1611
175
1
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENST00000256367 ⟹ ENSP00000256367
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 14 70,641,916 - 70,675,366 (+) Ensembl
RefSeq Acc Id:
NM_015351 ⟹ NP_056166
RefSeq Status:
REVIEWED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 14 70,641,916 - 70,675,366 (+) NCBI GRCh37 14 71,108,504 - 71,142,077 (+) RGD Build 36 14 70,178,257 - 70,211,830 (+) NCBI Archive Celera 14 51,172,455 - 51,206,028 (+) RGD HuRef 14 51,277,148 - 51,310,717 (+) ENTREZGENE CHM1_1 14 71,046,680 - 71,080,246 (+) NCBI T2T-CHM13v2.0 14 64,847,902 - 64,881,350 (+) NCBI
Sequence:
GTCCGAGGCGGCGGCGGCGGCGGCTGGAGCAGCCTCTGGCAGCAGCGGGGAGAATGGGAGTGCGGGGCGCCAGACCGCCGCGGGGTGTCACGGCCGCCACGAAGCCTGCGAGGCGCGGGGCCGGCGCC CGCGGCTTTTAAACCCGGGAAGGCGCGGCGGCGGCGGCGGCGGCGGGCAGATCGCGGCGCGCACCAGGCGCCGGGGCGGCGGCCGAATGGAGAGAAAGGGCTCGGCGGCCGGGGCCAAGGGGAACCCG AGCCCGCCCGCGGCCGGAGAGGGGCAGCGGCCACCGCCGCCGCTGTGCGTCCCGGGCGGCGGCGGAGGAGCCCCAGCGAGGGGCCAGGTCGGGGCGGCGGCCGAGCCGGCCGAGCTCATCCGACGAGC GCACGAGTTCAAAAGCCAAGGGGCGCAGTGCTACAAGGACAAGAAATTCCGTGAAGCCATAGGCAAATACCACCGGGCGTTGCTGGAGCTGAAGGGGCTGCTGCCGCCCCCCGGGGAACGGGAGCGGG ACTCGCGCCCGGCCTCCCCGGCTGGGGCCCTGAAGCCCGGCCGCCTCTCGGAGGAGCAGAGCAAGACGGTGGAAGCCATCGAGATCGACTGTTACAACAGCCTGGCAGCCTGCCTGCTCCAGGCTGAG CTGGTAAACTATGAACGAGTCAAGGAATATTGCCTCAAAGTCTTGAAGAAGGAAGGGGAGAACTTCAAGGCCCTTTACCGGTCTGGTGTGGCCTTCTACCACCTTGGGGACTATGACAAAGCACTCTA CTACCTGAAAGAAGCAAGGACCCAACAACCAACAGACACCAACGTGATTCGGTATATCCAGCTGACGGAGATGAAACTCAGCCGATGCTCCCAGAGAGAAAAAGAAGCCATGTAACCAGGAAGCAGCT CCAGAGCTGCGCCCACGCCTGACCGGGGACTTCCAGGCATCCCCTGGCAGAGAGCCCCGTCCTGGATTCTGTCCCTTTCTCCCCACTTCTTCTGGCTCCTCATTTTTCCTCCTGTTGCACCCCAGCTC TTTGTCTCCTCCCAGTACGAAAAGGAGAGATGCAAATTTGGAATCTGGTAGGTCGCCCAGACAATGGAGACATCCTCTCCTCTAGCAGGTCAGCGACTGAGAGGGGCCTGACTTCTGCTGGGACAGCT GGAGAGGAGTCTCATGGGCTGGGATGCTGTTGTGGCTTTGACTTTGGCCAGTGCTTCTGACAGAGGCGGAGCCTGGCAAGTGTACCATCCCACAGGCAGCAGGCACACAGCCCATGGGCTGGATCCTT CCACACTTTCCTGACAGACCAGAACCAGAGCATCTCGAGGCAACTGTTAGAAATCCAGGGACGAGACAAACAGAGAAGCGCTGGTGAAGCCAACATAGAGACTGTCAATGTGTACACTGGAGTTCCCA CCCCCACCCCCCACCCGTCACTTAGCCCCTGCCTCCTTCCCCCACTCGTTGTCTTGGCTTGTGCTTTCTCCTCTCCCCATCGGGGATCCGAGACTCTGCCAGGATTCACATGCCACTGAAGCCCACTC AGTGCCCTCTGGTGACCACACATACCATTCCCCCGGACTCCCACCCAGCAGGCAGCTGTGACCGCAGAAGGGCAGGATGAAGTGGGCCAAGGTTTGGGACAGGTTGACTGTGTAGGTGACAGGGAGGG AAAGATGATGGCCAGGGGAAAGAGCATCGTATAGGCTAGGGGATTGAACTGTGGACTGATTCAGTGTAAATAAAAACAAATTAACAGGTAGTAGTTCCTGTCAGTTCTGTTGGAAGCAGCCCACTCCC TCACTTTTACTCCTTCCTCCAACCCTCAATCAGAGCTACTTACAGCCAGGCAGGATGGGGCTTTCCCCAAAGCAATTGGCCGTTTGTCCAGTGGCAGACAATGGTGGCTACAGCCTTTGTGCTTTTAA GAGTGGGCTGGGATTGTGGAGACTGCCCAGGGGCTTGGCTTTGTCAGAACTTGTACAATCTTCTTTTGATGAAATTATCTGAACTCAACATCTAGCACATAGAATGTGTTCAACAAATGCTTGTTGAA TGAATAAATTATGACTGCAGACTGGCTCTCCTGCCTTAAACTAATTTCATCCCAGCCTAGTCTCCTGATGTCTGTGCTCGTTATGCTATGCCATGTTGCTTCAGTCAAACAAGAAACACTTACTGAGG GCATATTGTTTGCCCATCATTGTGCAATATGCTGTGGGACATGGGATGTCGTCTCAGTCTTCAAGGAAATGGAAGGGTTAAGAAATGCATATGAGATTATTACCAATGACACCGTTAATTTATATGAT GCTTTAAAATTATCAGAGCACTTTCATGTATTTTTCGTGTGACTAGTGAAAAAGACAATGTTGTACAAAATTAAAATATATACAGATGCAATAATGTGAATAGTTAGGATTTATTAAATGCATTATCT TCAGATCTTTACATGTATAATCTCATTTCTTTCATGCAGTTACTCTGGGATACTGTTCCCATTTGATGGGTAAGAATATTGAAAACCAGAAAAATTAATTATCCCAAGGTTGCATGGCCTTTAGTGGC ATAGCTAGGATTTGAACCAGGCCTGCCTGACTCCAGAGCTCTGGCTAGTATCTATGCTATACTTAGTTGCCTCTCTGTAAGTATAATATTGGGCAATTATAACCATTTGAGAACAGGACAATATGTAT TAACCTGAAAAGTGTTCATGATGTCAGTGATAGTACATGGCCTCCTTATGTATTTACTCAAGGGCCCCAAAAGACCAGAGGCCAGAATCCCTAGTAGTCAGAGCAGTGACAGGTCAGAAAAAGGCAGC TGAGGTCCAATAGTTATGTCTGTGTATTGCTCATTCTACTTACTGATGGAGCCAGCATGTATCTCAACAACTCACCTAGCATTCATCACCCATCCCCAGCATTGGGAAAGGGTCACAATTAAGACCGA AAGGAAACACAAAGTTAAATATGGGTTAATTATGTAAGCAGATGCCCCACCACGGCAGGATCCAATCACAGCCGAGGGGCCCAGAAGAGAGCAGCGTAAGTTATATTCACATAGTTCCCCAAAGGCTT TCAACGGGGGCTACAGGAAGGTGCTAGAAATATTGAGGGGCCTGCCATTACTCACCTAGAGCTCACTCTCTGGAGAAGAGGAAAAGGAAGAAGCTATTTCAGCTGCCACATTCTCCCCAATCCCTACT ATATTATGCTGTCTTTCCTCTTCCTCCTAGCTGGCTTTACATGACCCTAACCCAAAACTACCCTATGGCCCCACACGGGAATGTGTTCAAACGCCCCGACCCCCACCCCCACCCCCATTCCCAAGCCT CCAACTTAGAACGTTTGTGATTTGGCAGATGGTTTGTTAGGATCTGAAGGATGAAGAGAAGGGTAGAGGTCACCTGGAGAATGAGTTCAAACTGCCAGGGTCTTCCCTTGGTCTTTGTGCGTCAGGAA GGACTCCGAGTAATTATTCCCTATGCAGAGACAGGAGAGAGGTCTTGTTTACATGAGTGTGCTGGGGCAGGGCTGGACAATCCAGGATATGATTGTAGCCATCCCATGTAGAAAGATCAAAAACCAGA ACGAAATGAAGACAGCCTCTCAGAACCTCATAGAACAAGCGTCCAGGTCATCTGCTTGTTTGGTGACTTAGATATACAGGCTTACTGGAACTCCATTCACTGTGACCTGAAGTTAAATAATCCCAAAG AGAAAAAGCTACCTGGGGTATTGGTTGATGTTTGGGGTGATAGGGCTGAATTTTCTGTGCATTTGTCCAACAAAGGCTTTAGAGCACAAAACCAGGTTCATTCTCCCTACCAAATCTTCAGCTTCCTT CTCCTCATCCCTCCCCAAAACAAGAACTGTGATTTAATTCCGTACGTTGCGGATGTCACTGCTGACCTATGTAGCTGGAGTACTAATCAGGCATCTGACCTGCACTGTCATCCCCTGCCTGGACTTTT GCGATGGACTCTTTGGGGGAAAAACTAACGCTTTTTAATTATTGTGAAAGCATCATGTGTGTATTGTAGAAGTTTTAGGAAAAAAAGGACAAAATCCAATCCATAAGCTTACCACCCAAGACAAACGT GTATTCTTTTGAATATACCTTTTAGTTCTTTTTGGTGTAAATGTACACACGCACACACAGTTGTGGATTTTTTTAAACAAAAACTGGATACACTGAATATACTCTTTAATAACTTTTCAAGTGTGTAT TTATATTTTAGAATATGTAATCCTACACAGATACAAAATTCAAAAAGTACAAACTGCTCTGTAGTCAGAAGTAAATCTTCTCCCTACCCCGTCTGCCAGCATCTAGTTTCCCTCTAATTTATTTTGCA TCCTAGTGGAGATGCTTACACATTGTCAAACATATGTATATATTCTTTTATCACACACAAATGGCAGCATATTGGACACTTTTTGTTTTTTGCTCCTTCTGTTCCTTCACTTAATAATATCACGAACA TTTTCGGCATATCAAACTTTCTCAACAGCATCTTCATTGTATGGATGGACCCTTTTTTTATCATCAATCCTCAAATAGTGATTATTTCATTTGTTCCCAATCTTCATTGTAAATAGTGTTGCAACTGA CATTCTTGTAGCTAAATTTTGCACATGTCTATAACGATTTCCTTAGGATAAACTCCAAGAAGAGACTTGCTTGGCTATTTTTAAGAATTTTGATACATGTTGCCAACCACCCTCCAGAAAGTTTGTAC CAAAACGCTCTCCTATTTGGATCCTAGAGAGTACCCTGTTTCCTGCACCCTAACACTAGGTATCATCACTTATCAAATCTTTCCCAATTTGGTAGCTGGGATAATAGTATGTCAATGTTATTTTAACT TTCTTTGATTCTTCGCGAATAACATTTTCATATGCTTATTGACCATTTGTACTTCTTTCTTTGTGAATTTTCTATTTATTTGATATTGGTATGTTTATTATCAATTTGTAATTTTATTAAGAATATTA TTTTTGTCAAGAAATGCTGCAAATATGCTTTCCAAGTGCTTTGCTTTCAAATTTTGTTTATGGTGCTTTTTGACATACATAAATTCTTAATTCTGCAATTAA
hide sequence
RefSeq Acc Id:
NP_056166 ⟸ NM_015351
- UniProtKB:
Q86WT2 (UniProtKB/Swiss-Prot), Q92623 (UniProtKB/Swiss-Prot)
- Sequence:
MERKGSAAGAKGNPSPPAAGEGQRPPPPLCVPGGGGGAPARGQVGAAAEPAELIRRAHEFKSQGAQCYKDKKFREAIGKYHRALLELKGLLPPPGERERDSRPASPAGALKPGRLSEEQSKTVEAIEI DCYNSLAACLLQAELVNYERVKEYCLKVLKKEGENFKALYRSGVAFYHLGDYDKALYYLKEARTQQPTDTNVIRYIQLTEMKLSRCSQREKEAM
hide sequence
Ensembl Acc Id:
ENSP00000256367 ⟸ ENST00000256367
RGD ID: 6791997
Promoter ID: HG_KWN:19690
Type: CpG-Island
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, K562, Lymphoblastoid
Transcripts: NM_015351, UC001XMH.1
Position: Human Assembly Chr Position (strand) Source Build 36 14 70,177,706 - 70,179,317 (-) MPROMDB
RGD ID: 7228037
Promoter ID: EPDNEW_H19764
Type: initiation region
Name: TTC9_1
Description: tetratricopeptide repeat domain 9
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H19765 EPDNEW_H19766
Experiment Methods: Single-end sequencing.; Paired-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 14 70,641,663 - 70,641,723 EPDNEW
RGD ID: 7228039
Promoter ID: EPDNEW_H19765
Type: initiation region
Name: TTC9_2
Description: tetratricopeptide repeat domain 9
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H19764 EPDNEW_H19766
Experiment Methods: Single-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 14 70,641,788 - 70,641,848 EPDNEW
RGD ID: 7228041
Promoter ID: EPDNEW_H19766
Type: initiation region
Name: TTC9_3
Description: tetratricopeptide repeat domain 9
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H19764 EPDNEW_H19765
Experiment Methods: Single-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 14 70,641,916 - 70,641,976 EPDNEW